RAFAEL HOLDINGS, INC. Interest Income Interest Earning Asset
RAFAEL HOLDINGS, INC. (RFL) reported Interest Income Interest Earning Asset of $38.00 thousand for the 3-month period ending 2024-01-31, per its 10-Q filed 2024-03-14.
Discontinued › Income Statement › Other Income
us-gaap:InterestIncomeInterestEarningAsset · last filed 2024-03-14
- RAFAEL HOLDINGS, INC. interest income interest earning asset for the quarter ending 2024-01-31 was $38.00K.
- RAFAEL HOLDINGS, INC. interest income interest earning asset for the quarter ending 2023-10-31 was $91.00K.
- RAFAEL HOLDINGS, INC. interest income interest earning asset for fiscal 2023 was $54.00K.
| Period end | Interest Income Interest Earning Asset 3 month | Interest Income Interest Earning Asset 6 month | Interest Income Interest Earning Asset 12 month |
|---|---|---|---|
| 2024-01-31 | $38.00K 10-Q · filed 2024-03-14 | $76.00K 10-Q · filed 2024-03-14 | |
| 2023-10-31 | $91.00K 10-Q · filed 2023-12-14 | ||
| 2023-07-31 | $54.00K 10-K · filed 2023-10-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |